Pain, MenstrualNCT03593850
Music for Pain in Primary Dysmenorrhea
A study testing Music group and Silence Group in people with Pain, Menstrual and Primary Dysmenorrhea, run by Universidad del Rosario at 1 site in Colombia.
Trial summary
Primary dysmenorrhea is defined as lower abdominal pain that occurs during menses and is not secondary to any type of pelvic disease. It is considered the most common condition in reproductive age women. First line of treatment are non-steroidal anti-inflammatory drugs (NSAIDS), or oral contraceptives (OCC). Read more about this study
- Who is it for?
- Ages 18 years and older, women onlyHealthy volunteers can take part
- Conditions the study is for
- Pain, Menstrual, Primary Dysmenorrhea
- What is being tested?
- Music group and Silence Group
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 649 participants
- Where
- 1 siteColombia
- Study dates
- 1 Sep 2017to 17 Apr 2018
- Phase
- Interventional
- Are there results?
- Yes, posted in the registrySummary in the doctors' view
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- Women only
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Legal and cognitive capacity for informed consent.
- Suffering from primary dysmenorrhea (low abdominal pain associated to menses).
- Being able to understand and use the measuring tools and questionnaires.
Who cannot join
- Previous diagnosis of pelvic pathology.
- Diagnosis of hearing impairment.
- Diagnosis of neurologic or endocrinological disease.
- Psychiatric condition diagnosed.
- Known or reported previous substance abuse.
- Current use of psychiatric drugs.
Show all 12Show fewer
- Cancer diagnosis
- Diagnosed diabetes mellitus or heart disease.
- Previous advance musical training (defined as any form of music training in addition to that received during normal school classes).
- Irregular menstrual cycles.
- Previous pregnancy.
- Current use or use of any hormonal contraceptive therapy in the last 2 months.
Trial locations and contacts
1 site in 1 country.
Colombia1 site
Escuela de Medicina y Ciencias de la Salud- Universidad del Rosario
Bogotá, Capital District, 111211
About this study
Official title: Music for the Management of Pain in Primary Dysmenorrhea in Students of the School of Medicine and Health Sciences From the Universidad Del Rosario
Primary dysmenorrhea is defined as lower abdominal pain that occurs during menses and is not secondary to any type of pelvic disease. It is considered the most common condition in reproductive age women. First line of treatment are non-steroidal anti-inflammatory drugs (NSAIDS), or oral contraceptives (OCC). This two forms of treatment have not demonstrated 100% efficacy, and adverse events and contraindications for both exist. Moreover, studies have demonstrated that an important women do not use, or don't like to use, pharmacological treatment. Music have demonstrated analgesic effects in different clinical contexts, and has emerged as an important form of complementary therapy in the management of pain. To the researcher's knowledge, no studies have been conducted to evaluate music's effectiveness in pain secondary to primary dysmenorrhea.
The following is the protocol for a randomized, single blinded, clinical trial, where an experimental group listened to a 30 minute song, and was compared to a control group that rest in silence for the same time and conditions. It was expected that music will produce a larger, and significant, effect on pain reduction when compared to the control silence group according to pain measured through a 10 cm Visual Analogue Scale (VAS) in young women from the School of Medicine and Health Sciences at the Universidad del Rosario, Bogota DC, Colombia. Additionally, the investigators wanted to evaluate the clinical effect of music and analgesic requirements, anxiety and vital signs were also measured.
Read the detailed description
Primary Dysmenorrhea (PD) is defined as pain in the lower abdomen, that occurs always during menses, in the absence of pelvic pathology, and lasts about 24-72 hours. It initiates during the first 24 months after menarche. Other symptoms like, emotional lability, anxiety, nausea, headache, and others may accompany the pain. It is considered the most common condition of reproductive age women, and is considered one of the most important causes for school or work absence in this population.
Music has been proposed as a complementary therapy for the management of pain, and a large body of clinical evidence supports its use on clinical context. Additionally, functional imaging research has found that music activates areas related to pain modulation and perception like the periaqueductal gray matter. Moreover music seems to modify brain activity during pain perception. Music has been shown to be effective in relieving pain secondary to surgery, in cancer related pain, and other types of pain, but it has not been studied for primary dysmenorrhea.
This randomized clinical trial was designed with the following objectives
General Objective: To evaluate the efficacy of music listening, compared to a control group that rested in silence, in the painful experience secondary to primary dysmenorrhea in women of 18 years or older from the School of Medicine and Health Sciences at the Universidad del Rosario, Bogotá DC., Colombia.
Specific Objectives:
- Description of demographic data, clinical, gynecological, and obstetric background from the study population.
- Description of pain management, secondary to PD, used by the study population.
- Evaluate the usual pain secondary to PD, as reported by the study participants through a Visual Analogue Scale (VAS)
- To explore if the acute perception of pain secondary to PD, as reported by participants using a VAS, before the intervention, is different between the study groups.
- To evaluate if the acute perception of pain secondary to PD, as reported by participants using a VAS, after the intervention, differs between those that listened to music and those that rested in silence.
- To explore if a difference in the reduction of pain, as reported by participants using a VAS, from the moment before to the moment after the intervention exists between those in the music group compared to those in the silence group.
- To evaluate if the acute perception of pain secondary to PD, as reported by participants using a VAS, 3-6 hours after the intervention, differs between those that listened to music and those that rested in silence.
- To evaluate if the anxiety secondary to PD, as reported by participants using a validated Spanish short version of the Zung scale, differs between groups, before and after the intervention.
- To evaluate if a difference in the reported requirements of analgesic drugs is different between the study groups after and 3-6 hours after the intervention.
- To evaluate if a difference in heart rate, systolic and diastolic blood pressure is identified between groups, using a previously calibrated digital sphyngmomanometer.
The investigators hypothesized that listening to an instrumental song, unknown to the patient, will have a significant effect on pain relief. Additionally, investigators hypothesized that music listening will have a clinical effect big enough to also impact analgesic requirements and anxiety scores .
Primary endpoint was pain reduction from the moment before to after the intervention. Pain reduction is the better way to evaluate analgesia efficacy and was the proper approach for these protocol's main objective, which was efficacy of music on pain relief secondary to primary dysmenorrhea.
For achieving these aims and answering research questions, a randomized clinical trial was designed. As patients can't be blinded from listening or not to music, a single blinded approach was decided. Furthermore, methodology for recruitment was designed to blind patients from allocation until the day of the intervention and a speech was used to avoid patients to identify the primary endpoint. Additionally, patients were explained that two interventions were used, but it was not specified that silence group was the control group, to assure proper blinding and avoid further bias of results. Silence was decided as a control intervention as comparison with drug placebo may not be adequate due to differences in the types of intervention.
To isolate the music effects the investigators decided on using a completely new and unknown song. The song was planned and composed exclusively for the research, so all patients allocated to the music group listened to the exact same musical piece.
- Conditions
- Pain, Menstrual, Primary Dysmenorrhea
- Being tested
- Music group, Silence Group
- Keywords
- Pain management, Pain, Primary dysmenorrhea, Music, Music Therapy
- Medical subject headings
- Dysmenorrhea, Agnosia, Pain
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Music groupBehavioural
Also called Occasio adolore
The song was composed on a C major scale and a 60 bpm tempo. The song was composed with high consonance using simple melodic progressions on the C major scale, and using natural positions for chords. No percussion or lyrics were used for the song, and the following instruments were used in the composition: electric guitar and keyboards, violin (digital), cello (digital), clarinet (digital), synthesizers (digital), and fretless bass (digital).
Silence GroupBehavioural
Also called Silence
Audio file that contained no sounds.
| Study group | Role | What they receive |
|---|---|---|
| Music group | Experimental | Patients in this arm listened through headphones to a song of 29 minutes and 32 seconds duration. The song was composed entirely by investigator Juan Martin-Saavedra and registered to copyright and authorship regulatory entities from Colombia under the name "Occasio adolore" (Musical piece No. 5-559-355 and Phonogram No. 12-105-295 of Colombia's Copyright authorship agency). Patients were instructed to avoid using cellphones or other activities during the time of the intervention. Patients receive the intervention in the same room as the Silence group, but for the intervention they were always alone. The room was located in a low transit place with low ambient noise. Receives: Behavioral: Music group |
| Silence group | Active comparator | Patients on the silence group listened to a 29 minute and 32 second audio file that produced no sounds with headphones on. Patients were instructed to avoid using cellphones or other activities during the time of the intervention. Patients receive the intervention in the same room as the Music group, but for the intervention they were always alone. The room was located in a low transit place with low ambient noise. Receives: Behavioral: Silence Group |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in Pain From 1-5 Minutes Before (Baseline) to 1- 5 Minutes After the Intervention
Pain scores were measured using a visual analogue scale (VAS) of 10 cm (0 no pain at all, and 10 the worst possible pain) at each time point. Main outcome was calculated from the difference between visual analogue score at 1-5 minutes after (VAS3) minus visual analogue score at 1-5 minutes before the intervention (VAS2).
Measured: From 1-5 minutes before the intervention (baseline) to 1-5 minutes after the intervention.
Secondary outcomes (18)
Usual Pain Associated to Menses
Mean pain scores measured with a 10 cm visual analogue scale (VAS) where 0 was no pain at all and 10 the worst possible pain. Usual pain was evaluated before the intervention and was known as VAS 1.
Measured: 5-10 minutes before the intervention.
Actual Pain 1-5 Minutes Before the Intervention (Baseline).
Mean pain scores measured with a 10 cm visual analogue scale (VAS) where 0 was no pain at all and 10 the worst possible pain. Actual pain was evaluated immediately before the intervention and was known as VAS 2.
Measured: 1-5 minutes before the intervention.
Actual Pain 1-5 Minutes After the Intervention.
Mean pain scores measured with a 10 cm visual analogue scale (VAS) where 0 was no pain at all and 10 the worst possible pain. Actual pain was evaluated immediately after the intervention was completed, and was known as VAS 3.
Measured: 1-5 minutes after the intervention.
Actual Pain 3-6 Hours After the Intervention.
Mean pain scores measured with a 10 cm visual analogue scale (VAS) where 0 was no pain at all and 10 the worst possible pain. Actual pain was evaluated 3-6 hours after the intervention was completed, and was known as VAS 4.
Measured: 3-6 hours after the intervention.
Anxiety Score Before the Intervention
Using a validated short spanish version of the Zung anxiety scale, anxiety was measured before the intervention. The scale was composed of 10 items. Each item had a 4 Likert point scale (0= never, 1= some times, 2= most of the time, and 3 = always). Final scores ranged from 0, minimum anxiety, and 30 maximum anxiety.
Measured: 1-5 minutes before the intervention.
Anxiety Score After the Intervention
Using a validated short spanish version of the Zung anxiety scale, anxiety was measured after the intervention. The scale was composed of 10 items. Each item had a 4 Likert point scale (1= never, 2= some times, 3= most of the time, and 4 = always). Scores ranged from 10, minimum anxiety, and 40 maximum anxiety. For analysis, mean quantitative scores were obtained so 1 was equivalent to minimum anxiety, and 4 to maximum anxiety.
Measured: 1-5 minutes after the intervention.
Anxiety Score 3-6 Hours After the Intervention
Using a validated short spanish version of the Zung anxiety scale, anxiety was measured 3-6 hours after the intervention. The scale was composed of 10 items. Each item had a 4 Likert point scale (0= never, 1= some times, 2= most of the time, and 3= always). Scores ranged from 0, minimum anxiety, and 30 maximum anxiety.
Measured: 3-6 hours after fter the intervention.
Analgesic Requirements Before
Before the intervention patients were asked if they wanted to use any analgesic drug or do any kind of analgesic strategy. Patients simply answered yes or no.
Measured: 1-5 minutes before the intervention the intervention.
Analgesic Requirements After
After the intervention patients were asked if they wanted to use any analgesic drug or do any kind of analgesic strategy. Patients simply answered yes or no.
Measured: 1-5 minutes after the intervention.
Analgesic Use During a Period of 3-6 Hours After the Intervention.
After the intervention, all patients had to register all analgesic drugs (e.g. ibuprofen) or strategy (e.g. local heat) that were used until last pain measurement (VAS 4, 3-6 hours after the intervention).
Measured: 3-6 hours after the intervention)
Systolic Blood Pressure Before the Intervention
Systolic blood pressure in mmHg measured with a calibrated digital sphygmomanometer before the intervention.
Measured: 1-5 minutes before the intervention.
Diastolic Blood Pressure Before the Intervention
Diastolic blood pressure in mmHg measured with a calibrated digital sphygmomanometer before the intervention.
Measured: 1-5 minutes before the intervention.
Heart Rate Before the Intervention
Heart rate measured in beats per minute (bpm) with a calibrated digital sphygmomanometer before the intervention.
Measured: 1-5 minutes before the intervention.
Mean Blood Pressure Before the Intervention
Mean blood pressure in mmHg measured with a calibrated digital sphygmomanometer before the intervention.
Measured: 1-5 minutes before the intervention.
Systolic Blood Pressure After the Intervention
Systolic blood pressure in mmHg measured with a calibrated digital sphygmomanometer after the intervention.
Measured: 1-5 minutes after the intervention.
Diastolic Blood Pressure After the Intervention
Diastolic blood pressure in mmHg measured with a calibrated digital sphygmomanometer after the intervention.
Measured: 1-5 minutes after the intervention.
Heart Rate After the Intervention
Heart rate in beats per minute (bpm) measured with a calibrated digital sphygmomanometer after the intervention.
Measured: 1-5 minutes after the intervention.
Mean Blood Pressure After the Intervention
Mean blood pressure in mmHg measured with a calibrated digital sphygmomanometer after the intervention.
Measured: 1-5 minutes after the intervention.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted20 Jul 2018
- Study start1 Sep 2017
- Primary completion6 Apr 2018
- Study completion17 Apr 2018
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Posted resultsParticipant flow, outcome measures and adverse events reported by the sponsor.
- Other trials for Pain, MenstrualStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Single blinded, two parallel group, randomized clinical trial. The experimental group received listen to a son composed exclusively for this trial while control group rested for the same amount of time in silence.
- Masking
- Triple blind
- Who is masked
- Care provider, Investigator, Outcomes assessor
- Enrolment
- 649 participants (actual)
Sponsor and investigators
- Lead sponsor
- Universidad del Rosario
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Juan S. Martin-Saavedra, Universidad del Rosario
- Investigators
- Juan S Martin-Saavedra, MD, Principal investigator, Universidad del RosarioAngela M Ruiz-Sternberg, MD, MSc, Study director, Universidad del Rosario
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03593850
- Sponsor's protocol ID
- CEI856
- Status last verified
- May 2024
- First submitted
- 4 Jun 2018
- Last updated
- 28 May 2024
- Results posted
- Yes, on ClinicalTrials.gov
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: Results fromt the research will be made available as supplemental data or digital content published with the final manuscript. Additional information like the study protocol, statistic analysis plan performed, and copy of the informed consent will be available by request to the email: juans.martin@urosario.edu.co
Study at a glance
From the registry record, last updated by the sponsor on 28 May 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Music for the Management of Pain in Primary Dysmenorrhea in Students of the School of Medicine and Health Sciences From the Universidad Del Rosario
- ClinicalTrials.gov ID
- NCT03593850
- Acronym / sponsor ID
- CEI856
- Conditions
- Pain, Menstrual, Primary Dysmenorrhea
- Keywords
- Pain management, Pain, Primary dysmenorrhea, Music, Music Therapy
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 649 participants (actual)
- Lead sponsor
- Universidad del RosarioUniversity, hospital or other
- Study start
- 1 Sep 2017 (actual)
- Primary completion
- 6 Apr 2018 (actual)
- Study completion
- 17 Apr 2018 (actual)
- First posted
- 20 Jul 2018 (actual)
- Results
- Posted 28 May 2024
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Primary dysmenorrhea is defined as lower abdominal pain that occurs during menses and is not secondary to any type of pelvic disease. It is considered the most common condition in reproductive age women. First line of treatment are non-steroidal anti-inflammatory drugs (NSAIDS), or oral contraceptives (OCC). This two forms of treatment have not demonstrated 100% efficacy, and adverse events and contraindications for both exist. Moreover, studies have demonstrated that an important women do not use, or don't like to use, pharmacological treatment. Music have demonstrated analgesic effects in different clinical contexts, and has emerged as an important form of complementary therapy in the management of pain. To the researcher's knowledge, no studies have been conducted to evaluate music's effectiveness in pain secondary to primary dysmenorrhea.
The following is the protocol for a randomized, single blinded, clinical trial, where an experimental group listened to a 30 minute song, and was compared to a control group that rest in silence for the same time and conditions. It was expected that music will produce a larger, and significant, effect on pain reduction when compared to the control silence group according to pain measured through a 10 cm Visual Analogue Scale (VAS) in young women from the School of Medicine and Health Sciences at the Universidad del Rosario, Bogota DC, Colombia. Additionally, the investigators wanted to evaluate the clinical effect of music and analgesic requirements, anxiety and vital signs were also measured.
Detailed description
Primary Dysmenorrhea (PD) is defined as pain in the lower abdomen, that occurs always during menses, in the absence of pelvic pathology, and lasts about 24-72 hours. It initiates during the first 24 months after menarche. Other symptoms like, emotional lability, anxiety, nausea, headache, and others may accompany the pain. It is considered the most common condition of reproductive age women, and is considered one of the most important causes for school or work absence in this population.
Music has been proposed as a complementary therapy for the management of pain, and a large body of clinical evidence supports its use on clinical context. Additionally, functional imaging research has found that music activates areas related to pain modulation and perception like the periaqueductal gray matter. Moreover music seems to modify brain activity during pain perception. Music has been shown to be effective in relieving pain secondary to surgery, in cancer related pain, and other types of pain, but it has not been studied for primary dysmenorrhea.
This randomized clinical trial was designed with the following objectives
General Objective: To evaluate the efficacy of music listening, compared to a control group that rested in silence, in the painful experience secondary to primary dysmenorrhea in women of 18 years or older from the School of Medicine and Health Sciences at the Universidad del Rosario, Bogotá DC., Colombia.
Specific Objectives:
- Description of demographic data, clinical, gynecological, and obstetric background from the study population.
- Description of pain management, secondary to PD, used by the study population.
- Evaluate the usual pain secondary to PD, as reported by the study participants through a Visual Analogue Scale (VAS)
- To explore if the acute perception of pain secondary to PD, as reported by participants using a VAS, before the intervention, is different between the study groups.
- To evaluate if the acute perception of pain secondary to PD, as reported by participants using a VAS, after the intervention, differs between those that listened to music and those that rested in silence.
- To explore if a difference in the reduction of pain, as reported by participants using a VAS, from the moment before to the moment after the intervention exists between those in the music group compared to those in the silence group.
- To evaluate if the acute perception of pain secondary to PD, as reported by participants using a VAS, 3-6 hours after the intervention, differs between those that listened to music and those that rested in silence.
- To evaluate if the anxiety secondary to PD, as reported by participants using a validated Spanish short version of the Zung scale, differs between groups, before and after the intervention.
- To evaluate if a difference in the reported requirements of analgesic drugs is different between the study groups after and 3-6 hours after the intervention.
- To evaluate if a difference in heart rate, systolic and diastolic blood pressure is identified between groups, using a previously calibrated digital sphyngmomanometer.
The investigators hypothesized that listening to an instrumental song, unknown to the patient, will have a significant effect on pain relief. Additionally, investigators hypothesized that music listening will have a clinical effect big enough to also impact analgesic requirements and anxiety scores .
Primary endpoint was pain reduction from the moment before to after the intervention. Pain reduction is the better way to evaluate analgesia efficacy and was the proper approach for these protocol's main objective, which was efficacy of music on pain relief secondary to primary dysmenorrhea.
For achieving these aims and answering research questions, a randomized clinical trial was designed. As patients can't be blinded from listening or not to music, a single blinded approach was decided. Furthermore, methodology for recruitment was designed to blind patients from allocation until the day of the intervention and a speech was used to avoid patients to identify the primary endpoint. Additionally, patients were explained that two interventions were used, but it was not specified that silence group was the control group, to assure proper blinding and avoid further bias of results. Silence was decided as a control intervention as comparison with drug placebo may not be adequate due to differences in the types of intervention.
To isolate the music effects the investigators decided on using a completely new and unknown song. The song was planned and composed exclusively for the research, so all patients allocated to the music group listened to the exact same musical piece.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Triple blind (care provider, investigator, outcomes assessor)
- Number of arms
- 2
- Model description
- Single blinded, two parallel group, randomized clinical trial. The experimental group received listen to a son composed exclusively for this trial while control group rested for the same amount of time in silence.
| Arm | Type | Receives |
|---|---|---|
| Music group | Experimental | Behavioral: Music groupPatients in this arm listened through headphones to a song of 29 minutes and 32 seconds duration. The song was composed entirely by investigator Juan Martin-Saavedra and registered to copyright and authorship regulatory entities from Colombia under the name "Occasio adolore" (Musical piece No. 5-559-355 and Phonogram No. 12-105-295 of Colombia's Copyright authorship agency). Patients were instructed to avoid using cellphones or other activities during the time of the intervention. Patients receive the intervention in the same room as the Silence group, but for the intervention they were always alone. The room was located in a low transit place with low ambient noise. |
| Silence group | Active comparator | Behavioral: Silence GroupPatients on the silence group listened to a 29 minute and 32 second audio file that produced no sounds with headphones on. Patients were instructed to avoid using cellphones or other activities during the time of the intervention. Patients receive the intervention in the same room as the Music group, but for the intervention they were always alone. The room was located in a low transit place with low ambient noise. |
Who may qualify
- Ages
- 18 years and older
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- Legal and cognitive capacity for informed consent.
- Suffering from primary dysmenorrhea (low abdominal pain associated to menses).
- Being able to understand and use the measuring tools and questionnaires.
Key exclusion criteria (12 listed)
- Previous diagnosis of pelvic pathology.
- Diagnosis of hearing impairment.
- Diagnosis of neurologic or endocrinological disease.
- Psychiatric condition diagnosed.
- Known or reported previous substance abuse.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Music groupAlso: Occasio adoloreThe song was composed on a C major scale and a 60 bpm tempo. The song was composed with high consonance using simple melodic progressions on the C major scale, and using natural positions for chords. No percussion or lyrics were used for the song, and the following instruments were used in the composition: electric guitar and keyboards, violin (digital), cello (digital), clarinet (digital), synthesizers (digital), and fretless bass (digital). | Behavioural | Music group |
| Silence GroupAlso: SilenceAudio file that contained no sounds. | Behavioural | Silence group |
Primary outcome
Change in Pain From 1-5 Minutes Before (Baseline) to 1- 5 Minutes After the Intervention
Time frame: From 1-5 minutes before the intervention (baseline) to 1-5 minutes after the intervention.
Pain scores were measured using a visual analogue scale (VAS) of 10 cm (0 no pain at all, and 10 the worst possible pain) at each time point. Main outcome was calculated from the difference between visual analogue score at 1-5 minutes after (VAS3) minus visual analogue score at 1-5 minutes before the intervention (VAS2).
18 secondary outcomes
Usual Pain Associated to Menses
Time frame: 5-10 minutes before the intervention.
Actual Pain 1-5 Minutes Before the Intervention (Baseline).
Time frame: 1-5 minutes before the intervention.
Actual Pain 1-5 Minutes After the Intervention.
Time frame: 1-5 minutes after the intervention.
Actual Pain 3-6 Hours After the Intervention.
Time frame: 3-6 hours after the intervention.
Anxiety Score Before the Intervention
Time frame: 1-5 minutes before the intervention.
Anxiety Score After the Intervention
Time frame: 1-5 minutes after the intervention.
Anxiety Score 3-6 Hours After the Intervention
Time frame: 3-6 hours after fter the intervention.
Analgesic Requirements Before
Time frame: 1-5 minutes before the intervention the intervention.
Analgesic Requirements After
Time frame: 1-5 minutes after the intervention.
Analgesic Use During a Period of 3-6 Hours After the Intervention.
Time frame: 3-6 hours after the intervention)
Systolic Blood Pressure Before the Intervention
Time frame: 1-5 minutes before the intervention.
Diastolic Blood Pressure Before the Intervention
Time frame: 1-5 minutes before the intervention.
Heart Rate Before the Intervention
Time frame: 1-5 minutes before the intervention.
Mean Blood Pressure Before the Intervention
Time frame: 1-5 minutes before the intervention.
Systolic Blood Pressure After the Intervention
Time frame: 1-5 minutes after the intervention.
Diastolic Blood Pressure After the Intervention
Time frame: 1-5 minutes after the intervention.
Heart Rate After the Intervention
Time frame: 1-5 minutes after the intervention.
Mean Blood Pressure After the Intervention
Time frame: 1-5 minutes after the intervention.
Results and safety
Loading the posted results from ClinicalTrials.gov…
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 28 May 2024.
- Posted resultsParticipant flow, baseline, all outcome measures and adverse events.
- Individual participant dataSharing planned: Yes. Results fromt the research will be made available as supplemental data or digital content published with the final manuscript. Additional information like the study protocol, statistic analysis plan performed, and copy of the informed consent will be available by request to the email: juans.martin@urosario.edu.co
Related trials for Pain, Menstrual
Not yet recruiting
Radiofrequency and Pelvic Floor Exercise for Primary Dysmenorrhea
Primary Dysmenorrhea
Not yet recruitingPhase 2
PRECISION-E2: Teverelix in Women With Endometriosis - Pharmacodynamics, Safety and Precision Medicine Correlates
Endometriosis Pelvic, Endometriosis Ovaries
Not yet recruiting
Ultrasound-Guided Radiofrequency Ablation for Focal Adenomyosis
Adenomyosis, Adenomyoma of Uterus
Active, not recruiting
Mindfulness-Based Education For Women With Polycystic Ovary Syndrome
Polycystic Ovary Syndrome (PCOS), Menstrual Symptoms
Not yet recruiting
The Effect of a Ginger Formula on Menstrual Health vs a Placebo
Painful Menstruation
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Juan S Martin-Saavedra, MD principal investigator
Universidad del Rosario
Angela M Ruiz-Sternberg, MD, MSc study director
Universidad del Rosario
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Music group and Silence Group in people with Pain, Menstrual and Primary Dysmenorrhea, run by Universidad del Rosario at 1 site in Colombia.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 28 May 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Colombia. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Yes. Results are posted in the registry (first posted 28 May 2024). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in Pain From 1-5 Minutes Before (Baseline) to 1- 5 Minutes After the Intervention (time frame: From 1-5 minutes before the intervention (baseline) to 1-5 minutes after the intervention.). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 May 2024.